MedTrace Logo

Clinical Study of Lyophilized Plasma in Patients With Liver Disease

NCT01547078 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-03-18

No results posted yet for this study

Summary

A multi-center, phase 2, randomized, controlled study of the effect of lyophilized plasma in patients with liver disease.

Conditions

Interventions

BIOLOGICAL

Lyophilized Plasma

Licensed plasma that has been lyophilized.

BIOLOGICAL

Licensed Plasma

Plasma that has been authorized for transfusion.

Sponsors & Collaborators

  • HemCon Medical Technologies, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01547078 on ClinicalTrials.gov